Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction

Andrew Sharp; Christine Cornforth; Richard Jackson; Jane Harrold; Mark A. Turner; Louise Kenny; Philip N. Baker; Edward D. Johnstone; Asma Khalil; Peter von Dadelszen; Aris T. Papageorghiou; Zarko Alfirevic

doi:10.1016/S2352-4642(19)30020-3

Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction

Andrew Sharp, Christine Cornforth, Richard Jackson, Jane Harrold, Mark A. Turner, Louise Kenny, Philip N. Baker, Edward D. Johnstone, Asma Khalil, Peter von Dadelszen, Aris T. Papageorghiou, Zarko Alfirevic

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Pages (from-to)	e2-e3
Number of pages	2
Journal	The Lancet Child and Adolescent Health
Volume	3
Issue number	3
DOIs	https://doi.org/10.1016/S2352-4642(19)30020-3
Publication status	Published - Mar 2019

Access to Document

10.1016/S2352-4642(19)30020-3

Cite this

Sharp, A., Cornforth, C., Jackson, R., Harrold, J., Turner, M. A., Kenny, L., Baker, P. N., Johnstone, E. D., Khalil, A., von Dadelszen, P., Papageorghiou, A. T., & Alfirevic, Z. (2019). Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction. The Lancet Child and Adolescent Health, 3(3), e2-e3. https://doi.org/10.1016/S2352-4642(19)30020-3

@article{82533803c9ef47da9fed72e706bcfe5b,

title = "Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction",

author = "Andrew Sharp and Christine Cornforth and Richard Jackson and Jane Harrold and Turner, {Mark A.} and Louise Kenny and Baker, {Philip N.} and Johnstone, {Edward D.} and Asma Khalil and {von Dadelszen}, Peter and Papageorghiou, {Aris T.} and Zarko Alfirevic",

year = "2019",

month = mar,

doi = "10.1016/S2352-4642(19)30020-3",

language = "English",

volume = "3",

pages = "e2--e3",

journal = "The Lancet Child and Adolescent Health",

issn = "2352-4642",

publisher = "Elsevier",

number = "3",

}

Sharp, A, Cornforth, C, Jackson, R, Harrold, J, Turner, MA, Kenny, L, Baker, PN, Johnstone, ED, Khalil, A, von Dadelszen, P, Papageorghiou, AT & Alfirevic, Z 2019, 'Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction', The Lancet Child and Adolescent Health, vol. 3, no. 3, pp. e2-e3. https://doi.org/10.1016/S2352-4642(19)30020-3

TY - JOUR

T1 - Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction

AU - Sharp, Andrew

AU - Cornforth, Christine

AU - Jackson, Richard

AU - Harrold, Jane

AU - Turner, Mark A.

AU - Kenny, Louise

AU - Baker, Philip N.

AU - Johnstone, Edward D.

AU - Khalil, Asma

AU - von Dadelszen, Peter

AU - Papageorghiou, Aris T.

AU - Alfirevic, Zarko

PY - 2019/3

Y1 - 2019/3

UR - http://www.scopus.com/inward/record.url?scp=85061374987&partnerID=8YFLogxK

U2 - 10.1016/S2352-4642(19)30020-3

DO - 10.1016/S2352-4642(19)30020-3

M3 - Comment/debate

C2 - 30704877

AN - SCOPUS:85061374987

SN - 2352-4642

VL - 3

SP - e2-e3

JO - The Lancet Child and Adolescent Health

JF - The Lancet Child and Adolescent Health

IS - 3

ER -

Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction

Access to Document

Other files and links

Cite this